HIV Citations List: July, 2016

Literature Citations

1. A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin alpha(4)beta(7) and Fails to Prevent Mucosal Transmission of SHIV-SF162P3. Arrode-Bruses, G., D. Goode, K. Kleinbeck, J. Wilk, I. Frank, S. Byrareddy, J. Arthos, B. Grasperge, J. Blanchard, T. Zydowsky, A. Gettie, and E. Martinelli. Plos Pathogens, 2016. 12(6): e1005720. ISI[000379345300052].
[WOS]. HIV_07_2016.

2. HIV-Inhibitory Michellamine-type Dimeric Naphthylisoquinoline Alkaloids from the Central African Liana Ancistrocladus congolensis. Bringmann, G., C. Steinert, D. Feineis, V. Mudogo, J. Betzin, and C. Scheller. Phytochemistry, 2016. 128: p. 71-81. PMID[27137461].
[PubMed]. HIV_07_2016.

3. Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group. Bungard, C.J., P.D. Williams, J.E. Ballard, D.J. Bennett, C. Beaulieu, C. Bahnck-Teets, S.S. Carroll, R.K. Chang, D.C. Dubost, J.F. Fay, T.L. Diamond, T.J. Greshock, L. Hao, M.K. Holloway, P.J. Felock, J.J. Gesell, H.P. Su, J.J. Manikowski, D.J. McKay, M. Miller, X. Min, C. Molinaro, O.M. Moradei, P.G. Nantermet, C. Nadeau, R.I. Sanchez, T. Satyanarayana, W.D. Shipe, S.K. Singh, V.L. Truong, S. Vijayasaradhi, C.M. Wiscount, J.P. Vacca, S.N. Crane, and J.A. McCauley. ACS Medicinal Chemistry Letters, 2016. 7(7): p. 702-707. PMID[27437081]. PMC4948015[PMC4948015].
[PubMed]. HIV_07_2016.

4. Synthesis and in Vitro anti-HIV-1 Activity of a Series of N-Arylsulfonyl-3-propionylindoles. Che, Z.P., Y.E. Tian, Z.J. Hu, Y.W. Chen, S.M. Liu, and G.Q. Chen. Zeitschrift fur Naturforschung Section C-a Journal of Biosciences, 2016. 71(5-6): p. 105-109. PMID[27124676].
[PubMed]. HIV_07_2016.

5. Development of Synthetic Light-chain Antibodies as Novel and Potent HIV Fusion Inhibitors. Cunha-Santos, C., T.N. Figueira, P. Borrego, S.S. Oliveira, C. Rocha, A. Couto, C. Cantante, Q. Santos-Costa, J.M. Azevedo-Pereira, C.M. Fontes, N. Taveira, F. Aires-Da-Silva, M.A. Castanho, A.S. Veiga, and J. Goncalves. AIDS, 2016. 30(11): p. 1691-1701. PMID[27058352].

[PubMed]. HIV_07_2016.

6. Colony-stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to Trail-mediated Killing. Cunyat, F., J.N. Rainho, B. West, L. Swainson, J.M. McCune, and M. Stevenson. Journal of Virology, 2016. 90(14): p. 6255-6262. PMID[27122585]. PMCID[PMC4936142].
[PubMed]. HIV_07_2016.

7. The Discovery of Allyltyrosine Based Tripeptides as Selective Inhibitors of the HIV-1 Integrase Strand-transfer Reaction. Dalton, N., C.P. Gordon, T.P. Boyle, N. Vandegraaf, J. Deadman, D.I. Rhodes, J.A. Coates, S.G. Pyne, P.A. Keller, and J.B. Bremner. Organic & Biomolecular Chemistry, 2016. 14(25): p. 6010-6023. PMID[27225230].
[PubMed]. HIV_07_2016.

8. Triple Activity of Lamivudine Releasing Sulfonated Polymers against HIV-1. Danial, M., A.H. Andersen, K. Zuwala, S. Cosson, C.F. Riber, A.A. Smith, M. Tolstrup, G. Moad, A.N. Zelikin, and A. Postma. Molecular Pharmaceutics, 2016. 13(7): p. 2397-2410. PMID[27244595].
[PubMed]. HIV_07_2016.

9. Probing Lipophilic Adamantyl Group as the P1-ligand for HIV-1 Protease Inhibitors: Design, Synthesis, Protein X-Ray Structural Studies, and Biological Evaluation. Ghosh, A.K., H.L. Osswald, K. Glauninger, J. Agniswamy, Y.F. Wang, H. Hayashi, M. Aoki, I.T. Weber, and H. Mitsuya. Journal of Medicinal Chemistry, 2016. 59(14): p. 6826-6837. PMID[27389367].

[PubMed]. HIV_07_2016.

10. Prothymosin-alpha Variants Elicit anti-HIV-1 Response via TLR4 Dependent and Independent Pathways. Gusella, G.L., A. Teixeira, J. Aberg, V.N. Uversky, and A. Mosoian. Plos One, 2016. 11(6): e0156486. PMID[27310139]. PMCID[PMC4910978].
[PubMed]. HIV_07_2016.

11. High-mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii represent a potent anti-HIV Activity through High-affinity binding to the Viral Envelope Glycoprotein gp120. Hirayama, M., H. Shibata, K. Imamura, T. Sakaguchi, and K. Hori. Marine Biotechnology, 2016. 18(1): p. 144-160. PMID[26593063].
[PubMed]. HIV_07_2016.

12. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein. Jin, H., D. Li, H. Sivakumaran, M. Lor, L. Rustanti, N. Cloonan, S. Wani, and D. Harrich. mBio, 2016. 7(4). PMID[27381288]. PMCID[PMC4958243].
[PubMed]. HIV_07_2016.

13. Toll-interacting Protein Inhibits HIV-1 Infection and Regulates Viral Latency. Li, C., W.D. Kuang, D. Qu, and J.H. Wang. Biochemical and Biophysical Research Communications, 2016. 475(2): p. 161-168. PMID[27181351].
[PubMed]. HIV_07_2016.

14. Iron (II) Supramolecular Helicates Interfere with the HIV-1 Tat-Tar RNA Interaction Critical for Viral Replication. Malina, J., M.J. Hannon, and V. Brabec. Scientific Reports, 2016. 6(29674): 6pp. PMID[27405089]. PMCID[PMC4940744].
[PubMed]. HIV_07_2016.

15. Chemically Sulfated Natural Galactomannans with Specific Antiviral and Anticoagulant Activities. Muschin, T., D. Budragchaa, T. Kanamoto, H. Nakashima, K. Ichiyama, N. Yamamoto, H. Shuqin, and T. Yoshida. International Journal of Biological Macromolecules, 2016. 89: p. 415-420. PMID[27154517].
[PubMed]. HIV_07_2016.

16. Vitamin D3 Inhibits TNFalpha-induced Latent HIV Reactivation in J-LAT Cells. Nunnari, G., P. Fagone, F. Lazzara, A. Longo, D. Cambria, G. Di Stefano, M. Palumbo, L. Malaguarnera, and M. Di Rosa. Molecular and Cellular Biochemistry, 2016. 418(1-2): p. 49-57. PMID[27295094].
[PubMed]. HIV_07_2016.

17. Design, Synthesis and anti-HIV Activity of Novel Quinoxaline Derivatives. Patel, S.B., B.D. Patel, C. Pannecouque, and H.G. Bhatt. European Journal of Medicinal Chemistry, 2016. 117: p. 230-240. PMID[27105027].
[PubMed]. HIV_07_2016.

18. A Truncated Nef Peptide from SIVcpz Inhibits the Production of HIV-1 Infectious Progeny. Sabino Cunha, M., T. Lima Sampaio, B.M. Peterlin, and L. Jesus da Costa. Viruses, 2016. 8(7): E189 . PMID[27399760].
[PubMed]. HIV_07_2016.

19. Synergism of Alkaline Extract of the Leaves of Sasa senanensis Rehder and Antiviral Agents. Sakagami, H., K. Fukuchi, T. Kanamoto, S. Terakubo, H. Nakashima, T. Natori, M. Suguro-Kitajima, H. Oizumi, T. Yasui, and T. Oizumi. In Vivo, 2016. 30(4): p. 421-426. PMID[27381603].
[PubMed]. HIV_07_2016.

20. Efficient Inhibition of HIV Replication in the Gastrointestinal and Female Reproductive Tracts of Humanized BLT Mice by EFdA. Shanmugasundaram, U., M. Kovarova, P.T. Ho, N. Schramm, A. Wahl, M.A. Parniak, and J.V. Garcia. Plos One, 2016. 11(7): p. e0159517. PMID[27438728].
[PubMed]. HIV_07_2016.

21. The Design of 8-Hydroxyquinoline Tetracyclic Lactams as HIV-1 Integrase Strand Transfer Inhibitors. Velthuisen, E.J., B.A. Johns, D.P. Temelkoff, K.W. Brown, and S.C. Danehower. European Journal of Medicinal Chemistry, 2016. 117: p. 99-112. PMID[27092410].
[PubMed]. HIV_07_2016.

22. Abolishing HIV-1 Infectivity Using a Polypurine Tract-specific G-quadruplex-forming Oligonucleotide. Voges, M., C. Schneider, M. Sinn, J.S. Hartig, R. Reimer, J. Hauber, and K. Moelling. BMC Infectious Diseases, 2016. 16(1): p. 358. PMID[27450669]. PMCID[PMC4957839].
[PubMed]. HIV_07_2016.

23. 3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H. Wu, B., J. Tang, D.J. Wilson, A.D. Huber, M.C. Casey, J. Ji, J. Kankanala, J. Xie, S.G. Sarafianos, and Z. Wang. Journal of Medicinal Chemistry, 2016. 59(13): p. 6136-6148. PMID[27283261]. PMCID[PMC4945466].
[PubMed]. HIV_07_2016.

24. Molecular Cloning and anti-HIV-1 Activities of APOBEC3s from Northern Pig-tailed Macaques (Macaca leonina). Zhang, X.L., J.H. Song, W. Pang, and Y.T. Zheng. Dongwuxue Yanjiu, 2016. 37(4): p. 246-251. PMID[27469256].
[PubMed]. HIV_07_2016.

Patent Citations

25. Preparation of polycyclic-Carbamoylpyridone Compounds and Their Pharmaceutical Use. Bacon, E.M., Z.R. Cai, J.J. Cottell, M. Ji, H. Jin, S.E. Lazerwith, P.A. Morganelli, and H.-J. Pyun. Patent. 2016. 2015-14977347 20160176870: 101pp.

[Patent]. HIV_07_2016.

26. Preparation of Fused Pyrimidines as HIV Reverse Transcriptase Inhibitors Useful in Treatment and Prevention of HIV Infection. Jansa, P., M. Kvasnica, and R.L. Mackman. Patent. 2016. 2015-US308 2016105532: 79pp.

[Patent]. HIV_07_2016.

27. Preparation of Isoquinoline Compounds as HIV Reverse Transcriptase Inhibitors Useful in Treatment and Prevention of HIV Infection. Jansa, P., R.L. Mackman, Y.E. Hu, and E. Lansdon. Patent. 2016. 2015-US310 2016105534: 81pp.

[Patent]. HIV_07_2016.

28. Preparation of Quinazoline Derivatives for the Treatment of HIV Infection. Jansa, P., T. Simon, E. Lansdon, Y.E. Hu, O. Baszczynski, M. Dejmek, and R.L. Mackman. Patent. 2016. 2015-US460 2016105564: 185pp.

[Patent]. HIV_07_2016.